Valuation: BERI GROU

Market Cap 336K 233K 204K 188K 173K 330K 22.21M 2.25M 882K 10.95M 874K 855K 37.81M P/E 2024
-2.72x
P/E 2025 -0.07x
Enterprise Value 1.71M 1.19M 1.04M 956K 883K 1.68M 113M 11.45M 4.49M 55.72M 4.45M 4.35M 192M EV / Sales 2024
109x
EV / Sales 2025 2.68x
Free-Float
21.57%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 57 2016-06-16
Director of Finance/CFO 64 2018-07-01
Corporate Secretary 47 2021-02-28
Director TitleAgeSince
Chairman 57 2016-06-16
Director/Board Member 59 2016-11-02
Director/Board Member 55 2016-11-02
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-3.81% - - 218K
+0.09%+2.12%+56.49%+169.19% 1,084B
-1.63%+2.02%+66.31%+62.70% 634B
-1.12%-0.46%+31.69%+84.44% 447B
+0.18%+2.04%+30.19%+26.51% 330B
-6.22%-3.61%+29.15%+32.09% 295B
-1.27%-0.56%+27.21%+46.39% 285B
-0.93%-1.19%-28.85%-40.38% 218B
-1.19%+0.63%+22.43%+66.30% 199B
-0.72%+7.04%+21.41%+81.19% 169B
Average -1.03%+2.52%+28.45%+58.71% 406.65B
Weighted average by Cap. -0.86%+2.48%+39.76%+84.80%

Financials

2024 2025
Net sales 317K 220K 192K 177K 164K 312K 20.97M 2.12M 832K 10.34M 825K 807K 35.7M 638K 443K 387K 357K 330K 628K 42.25M 4.28M 1.68M 20.82M 1.66M 1.63M 71.93M
Net income -10.61M -7.36M -6.44M -5.94M -5.48M -10.43M -702M -71.12M -27.87M -346M -27.63M -27.03M -1.2B -4.22M -2.93M -2.56M -2.36M -2.18M -4.15M -280M -28.32M -11.1M -138M -11M -10.76M -476M
Net Debt -254K -177K -154K -142K -132K -250K -16.84M -1.71M -668K -8.3M -663K -648K -28.67M 1.37M 953K 833K 768K 710K 1.35M 90.83M 9.2M 3.61M 44.77M 3.58M 3.5M 155M
Logo BERI GROU
Beroni Group Limited is an Australia-based international biopharmaceutical company. The Company is focused on biomedicine, artificial intelligence, and modern technology research and development. Its businesses include cell therapies, developing new anti-cancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and the detection and diagnosis of infectious diseases. Its technology includes Brain Wave Extraction patent technology, a foundational technology in the Brain-Computer Interface (BCI) field, that enables the acquisition of high-resolution electroencephalogram (EEG) signals using a minimal number of electrodes, significantly enhancing the practicality and portability of BCI systems. Its product offering includes NicoBloc, CII-ArboViroPlex rRT-PCR assay and stem cell cosmetic products, including AGG Skin-Smoothing and Anti-Wrinkle Facial Mask, ODd Skin Repair Essence, ODd Beroni Beauty Facial Mask, and others.
Employees
-